Related Experiment Video
Updated: Jan 16, 2026

06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.9K
The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding.
Matthew E Larsen1,2, C Madison Barker1, Raul Satoshi Vargas1
1Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Biorxiv : the Preprint Server for Biology
|September 26, 2025
Summary
The Ca2+/Calmodulin(CaM)-dependent protein kinase II (CaMKII) D135N mutation impacts both enzymatic and structural functions, affecting synaptic strength and long-term potentiation (LTP) induction.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Long-term potentiation (LTP) is crucial for synaptic plasticity and memory formation.
- The role of Ca2+/Calmodulin(CaM)-dependent protein kinase II (CaMKII) in LTP is debated, with recent studies suggesting structural rather than enzymatic functions.
Purpose of the Study:
- To investigate the impact of the CaMKII D135N mutation on its enzymatic and structural functions in the context of LTP.
- To re-evaluate the role of CaMKII's enzymatic versus structural activity in synaptic potentiation.
Main Methods:
- Utilized the CaMKII D135N mutant to assess enzymatic activity (kinase activity, autophosphorylation at T286) and structural function (binding to GluN2B, co-condensation).
- Employed the T286A mutant and AS283 inhibitor for comparative analysis and functional rescue experiments.
Main Results:
- The D135N mutation abolished CaMKII enzymatic activity and T286 autophosphorylation.
- D135N mutation reduced GluN2B binding and prevented co-condensation with GluN2B, indicating an impact on structural function.
- Partial rescue of GluN2B binding by AS283 was observed, similar to the T286A mutant.
Conclusions:
- The D135N mutation affects both enzymatic and structural properties of CaMKII, complicating its use in distinguishing between these functions.
- Despite the observed effects on structural function, the D135N mutant data, when interpreted cautiously, still support a structural role for CaMKII in LTP induction.
Keywords:
Ca2+/calmodulin-dependent protein kinase II (CaMKII)N-methyl-D-aspartate receptor (NMDA receptor, NMDAR)long-term potentiation (LTP)synaptic plasticityMore Related Videos
Related Concept Videos
Calmodulin-dependent Signaling
6.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.0K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
Amplifying Signals via Enzymatic Cascade
17.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.5K

